Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications

Author(s):  Zur Eyal

Issue:  Nov/Dec 2018 - Volume 22, Number 6
View All Articles in Issue

Abstract:  Radiotherapy and epidermal growth factor receptor inhibitors, as important representatives of current chemotherapy, are crucial and irreplaceable treatments of modern oncology. These two types of treatments frequently cause severe dose-dependent dermatologic adverse events that can negatively affect a patient’s quality of life and compliance and cause inappropriate dose reductions and even treatment brakes. This article aims to emphasize new scientific data, published in peer reviews, regarding new possibilities to manage these debilitating dermatological adverse events. Since part of the scientific findings is new, the responsibility to enable pharmacologic treatment is in the compounding pharmacist domain. The article also suggests new formulations to the new pharmacologic treatment.

Related Keywords: Eyal Zur, BSc Pharm, RPh, MBA, cancer medicine, medical oncology, radiotherapy, epidermal growth factor receptor inhibitors, EGFR, dermatologic adverse events, acneiform rash, paronychia, inflammation, mucositis, xerosis, pruritus, hair changes, inflammatory changes, fingernails, keratinocytes, formulation, heparinoid cream, heparinoid lotion, topical preparations, ivermectin cream, ivermectin lotion, 5-aminolevulinic acid hydrochloride cream, case reports, radiation dermatitis, propranolol hydrochloride, topical corticosteroids


Printer-Friendly Version

Download in electronic PDF format for $55

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Zur Eyal Nov/Dec 2018 446-454 Buy
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum Zur Eyal Mar/Apr 2012 117-124 Buy
Oral Mucositis: Etiology and Clinical and Pharmaceutical Management Zur Eyal Jan/Feb 2012 22-33 Buy
Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia Zur Eyal Mar/Apr 2019 113-119 Buy
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol McKettrick Greg, Yoch Doug Jan/Feb 2021 18-23 Buy
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K Jan/Feb 2013 74-85 View Sample
Compounding with Biotechnology Products, Part 2: Product-specific Considerations Allen Loyd V Jr Nov/Dec 2022 446-466 Buy
Low-dose Pilocarpine Spray to Treat Xerostomia Zur Eyal Mar/Apr 2020 104-108 Buy
Imatinib 40-mg/mL Oral Suspension Allen Loyd V Jr Nov/Dec 2016 510 Buy
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso Jul/Aug 2014 278-286 Buy